A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ICM / ischemic cardiomyopathy

[Related PubMed/MEDLINE]
Total Number of Papers: 393
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ICM  (>> Co-occurring Abbreviation)
Long Form:   ischemic cardiomyopathy
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 10-year outcomes post coronary artery bypass grafting in Asian patients with ischemic cardiomyopathy: a comprehensive analysis of survival and cardiac performance. CABG, LVEF
2020 A susceptibility biomarker identification strategy based on significantly differentially expressed ceRNA triplets for ischemic cardiomyopathy. ceRNA
2020 Accurate Conduction Velocity Maps and Their Association With Scar Distribution on Magnetic Resonance Imaging in Patients With Postinfarction Ventricular Tachycardias. CV, EAM, LGE-CMR, VT
2020 Association between heart failure aetiology and magnitude of echocardiographic remodelling and outcome of cardiac resynchronization therapy. CRT, LVESV, NIDCM
2020 Dexmedetomidine Exerted Anti-arrhythmic Effects in Rat With Ischemic Cardiomyopathy via Upregulation of Connexin 43 and Reduction of Fibrosis and Inflammation. AMPK, BML, Cx43, DEX
2020 Direct and indirect mapping of intramural space in ventricular tachycardia. EH, IOM, NICM, NM, SEEM, VT
2020 Effects and Mechanisms of Traditional Chinese Herbal Medicine in the Treatment of Ischemic Cardiomyopathy. ---
2020 Feasibility and potential benefit of pre-procedural CMR imaging in patients with ischaemic cardiomyopathy undergoing cardiac resynchronisation therapy. CMR, CRT, LCR, LV, LVESV
2020 Impact of left ventricular assist device therapy on the cardiac proteome and metabolome composition in ischemic cardiomyopathy. DCM, LVAD, pre-LVAD
10  2020 Impact of paced left ventricular dyssynchrony on left ventricular reverse remodeling after cardiac resynchronization therapy. CI, CRT, LBBB, LV, OR, PLVD
11  2020 Ischaemic cardiomyopathy. Pathophysiological insights, diagnostic management and the roles of revascularisation and device treatment. Gaps and dilemmas in the era of advanced technology. ---
12  2020 Left ventricular endocardial pacing is less arrhythmogenic than conventional epicardial pacing when pacing in proximity to scar. APD, LV, VT
13  2020 Long-term clinical outcomes after placement of an implantable cardioverter-defibrillator: does the etiology of heart failure matter? HF, ICD, NICM
14  2020 Mechanical contraction to guide CRT left-ventricular lead placement instead of electrical activation in myocardial infarction with left ventricular dysfunction: An experimental study based on non-invasive gated myocardial perfusion imaging and invasive electroanatomic mapping. CRT, EAM, GMPI, LEA, LMC, LV, MI
15  2020 Myocardial Deformation Pattern Differs between Ischemic and Non-ischemic Dilated Cardiomyopathy: The Diagnostic Value of Longitudinal Strains. 2-D-STE, EF, LV, NICM
16  2020 Prognostic Value of Late Gadolinium Enhancement in Predicting Life-Threatening Arrhythmias in Heart Failure Patients With Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis. CI, ICD, LGE, MACE, NICM, OR, SMDs
17  2020 The Wearable Cardioverter-Defibrillator: Experience in 153 Patients and a Long-Term Follow-Up. ICD, NICM, SCD, WCD
18  2019 An altered left ventricle protein profile in human ischemic cardiomyopathy revealed in comparative quantitative proteomics. GO
19  2019 Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry. AF, CHF, HRs, NICM
20  2019 Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial. ICDs, NICM, WARCEF
21  2019 Association between serum copper and heart failure: a meta-analysis. CI, HF, IDCM, NOS, SMD
22  2019 Cardiac Proteome Profiling in Ischemic and Dilated Cardiomyopathy Mouse Models. ATP, DCM, HF, MI
23  2019 Combined Endocardial-Epicardial Versus Endocardial Catheter Ablation Alone forVentricular Tachycardia in StructuralHeart Disease: A Systematic Review and Meta-Analysis. ARVC, CI, endo, endo-epi, NICM, RR, RR, RR, VT
24  2019 Comparison between Glyceryl Trinitrate and Trimetazidine in Ischaemic Cardiomyopathy Patients. BSMMU, GTN, TMZ
25  2019 Comparison of In-Hospital Outcomes of Patients With-Versus-Without Ischemic Cardiomyopathy Undergoing Left Ventricular Assist Device Placement. CI, HF, LVAD, OR
26  2019 Comparison of Oxidative Stress Parameters in Heart Failure Patients Depending on Ischaemic or Nonischaemic Aetiology. HF, LVEF, MDA, nICM, OSI, OSP, PSH, TAC, TOS, UA
27  2019 Comparison of the Ventricular Tachycardia Circuit Between Patients With Ischemic and Nonischemic Cardiomyopathies: Detailed Characterization by Entrainment. NICM, VT
28  2019 Contemporary characteristics and outcomes of adults with familial dilated cardiomyopathy listed for heart transplantation. CI, FDCM, HR, HT, LVAD, NICM
29  2019 Distinct Circulating Expression Profiles of Long Noncoding RNAs in Heart Failure Patients With Ischemic and Nonischemic Dilated Cardiomyopathy. DCM, HF, lncRNA, mRNA
30  2019 Effect of Continuous-Flow Left Ventricular Assist Device Support on Coronary Artery Endothelial Function in Ischemic and Nonischemic Cardiomyopathy. CF-LVAD
31  2019 Eliciting alpha7-nAChR exerts cardioprotective effects on ischemic cardiomyopathy via activation of AMPK signalling. AMPK, CAP, LPS
32  2019 Feasibility of entirely subcutaneous ICD™ systems in patients with coronary artery disease. CAD, LVEF, SCD
33  2019 Genome-wide DNA methylation encodes cardiac transcriptional reprogramming in human ischemic heart failure. ---
34  2019 Impact of chronic total occlusion on ventricular arrhythmia and mortality in ischaemic cardiomyopathy patient with implantable cardiac defibrillator: a meta-analysis. ICD, VA
35  2019 Left Ventricular Thrombus After Acute Decompensated Heart Failure in the Setting of Ischemic Cardiomyopathy. ACS, CKD, HF, HFrEF, LV, SOB, TTE
36  2019 Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions. CI, CRT-D, ICDs, NICM, SVA
37  2019 Mean entropy predicts implantable cardioverter-defibrillator therapy using cardiac magnetic resonance texture analysis of scar heterogeneity. CMR-TA, ICD, NICM
38  2019 Molecular Alterations of Nucleocytoplasmic Transport in Patients on the Heart Transplantation Waiting List and Its Correlation With the Severity and Etiology of Heart Failure. ATPCa, DCM, ECMO, EXP4, HF, HT, IMP5, Nup153, Nup160, RanGAP1
39  2019 Multidisciplinary rounds in prevention of 30-day readmissions and decreasing length of stay in heart failure patients: A community hospital based retrospective study. CHF, HFpEF, HFrEF, MDR, NICM
40  2019 Outcome differences and device performance of the subcutaneous ICD in patients with and without structural heart disease. DCM, HCM, SCD
41  2019 Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland. EF, ICD, IQR, NICM, WCD
42  2019 Pacing in proximity to scar during cardiac resynchronization therapy increases local dispersion of repolarization and susceptibility to ventricular arrhythmogenesis. CRT, EP, HF, LV, VT
43  2019 Prognostic Impact of Ischemic Mitral Regurgitation Severity and Myocardial Infarct Quantification by Cardiovascular Magnetic Resonance. CMR, IMR, MIs, MRFraction
44  2019 Relationship of myocardial hibernation, scar, and angiographic collateral flow in ischemic cardiomyopathy with coronary chronic total occlusion. CMR, CTO, FDG, LGE
45  2019 Restrictive filling pattern in ischemic cardiomyopathy: Insights after surgical ventricular restoration. RFP, RWT, SVR
46  2019 Rho GTPase‑activating protein 1 promotes apoptosis of myocardial cells in an ischemic cardiomyopathy model. ARHGAP1
47  2019 Rivaroxaban Suppresses the Progression of Ischemic Cardiomyopathy in a Murine Model of Diet-Induced Myocardial Infarction. MI, PAR
48  2019 Significance of preoperative right ventricular function on mid-term outcomes after surgical ventricular restoration for ischemic cardiomyopathy. CI, LV, LVEF, MACEs, RR, RV, RVFAC, SVR
49  2019 Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis. AF, HF, HR, NICM, PS
50  2019 The Outcome of Diabetic Patients with Cardiomyopathy in Critical Care Unit: Hospital and Short-Term Outcome in a Period of Six Months to One Year. CAD, DM, GLS, HF, LV, LVEF, WMSI
51  2019 The Ubiquitin Proteasome System in Ischemic and Dilated Cardiomyopathy. eIF4E, MAFbx, MuRF1, UPS
52  2019 Value of 12-lead electrocardiogram to predict myocardial scar on FDG PET in heart failure patients. ECG, FDG, PET
53  2019 [Surgical Treatment of Ischemic Cardiomyopathy: Current State of the Problem]. STICH
54  2018 A cohort study of cardiac resynchronization therapy in patients with chronic Chagas cardiomyopathy. CCC, CRT, NYHA
55  2018 ASB1 differential methylation in ischaemic cardiomyopathy: relationship with left ventricular performance in end-stage heart failure patients. CNT, LV
56  2018 Association between myocardial extracellular volume and strain analysis through cardiovascular magnetic resonance with histological myocardial fibrosis in patients awaiting heart transplantation. CMR, CVF, DCM, ECV, MOLLI
57  2018 Beta-1-Adrenergic Receptor Antibodies in Acute Coronary Syndrome: Is Less Sometimes More? ACS, AP, NSTEMI, PET/CT, STEMI
58  2018 Bioinformatics analysis of common differential genes of coronary artery disease and ischemic cardiomyopathy. CAD, DAVID, GEO, GO, KEGG, PPI
59  2018 Bundle branch reentrant ventricular tachycardia: review and case presentation. BBRVT, ICD, NICM, WCT
60  2018 Can enhanced external counter pulsation as a non-invasive modality be useful in patients with ischemic cardiomyopathy after coronary artery bypass grafting? ACC, CABG, EECP
61  2018 CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DebrillAtor ThErapy international registry: Design and rationale of the DERIVATE study. CMR, ICD, LVEF, MACE, NICM, SCD, TTE, VT
62  2018 Cardiac resynchronization therapy: A comparative analysis of mortality in African Americans and Caucasians. ACEI, ARB, CI, CRT, GFR
63  2018 Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy. NICM, VT
64  2018 Cell Spray Transplantation of Adipose-derived Mesenchymal Stem Cell Recovers Ischemic Cardiomyopathy in a Porcine Model. ADSC
65  2018 Circulating miR-192 is a prognostic marker in patients with ischemic cardiomyopathy. miR
66  2018 Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy. DCM
67  2018 Comparison of ventricular tachyarrhythmia recurrence between ischemic cardiomyopathy and dilated cardiomyopathy: a retrospective study. DCM, ICD, LVEDV, LVEF, VF, VT
68  2018 Electrical latency predicts the optimal left ventricular endocardial pacing site: results from a multicentre international registry. AHR, BIVENDO, LV, LVENDO
69  2018 Electrophysiologic features of protected channels in late postinfarction patients with and without spontaneous ventricular tachycardia. CV, VT
70  2018 Epicardial ventricular tachycardia in ischemic cardiomyopathy: Prevalence, electrophysiological characteristics, and long-term ablation outcomes. ENDO, EPI, VT
71  2018 Etiologic impact on difference on clinical outcomes of patients with heart failure after cardiac resynchronization therapy: A systematic review and meta-analysis. CRT, LVEDD, LVEF, LVESV, NICM, PASP
72  2018 High-resolution three-dimensional late gadolinium-enhanced cardiac magnetic resonance imaging to identify the underlying substrate of ventricular arrhythmia. ARVC, CMR, HCM, HR-LGE, LGE, NICM, NSVT, SHD, VA, VF/SCD, VT
73  2018 Identification of a Common Different Gene Expression Signature in Ischemic Cardiomyopathy. DEGs, GO, RT-PCR
74  2018 Impact of Late Gadolinium Enhancement on mortality, sudden death and major adverse cardiovascular events in ischemic and nonischemic cardiomyopathy: A systematic review and meta-analysis. LGE, LVEF, NICM
75  2018 Impact of Number of Oral Antiarrhythmic Drug Failures Before Referral on Outcomes Following Catheter AblationofVentricular Tachycardia. AAD, SHD, VT
76  2018 Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death. CI, DAI-PP, ICD, NICM, SCD
77  2018 Implantable cardioverter-defibrillator therapy in hypertrophic cardiomyopathy: A SIMPLE substudy. CI, DCM, DT, HCM, HR, ICD, SIMPLE
78  2018 Improvement of increased cQTd is associated with heart function in patients with ischemic heart failure. CHF, DCM, ECG, LVEF, NYHA
79  2018 Increased Serum Interleukin-34 Levels Are Related to the Presence and Severity of Cardiac Dysfunction in Patients With Ischemic Cardiomyopathy. CAD, CI, CKD, CSF-1R, HF, IL-34, NYHA, OR
80  2018 Jeopardized Myocardium Defined by Late Gadolinium Enhancement Magnetic Resonance Imaging Predicts Survival in Patients With Ischemic Cardiomyopathy: Impact of Revascularization. JM
81  2018 Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy. CRT-D, CRT-P, HF, HR, MACE, NICM
82  2018 Myocardial viability-State of the art: Is it still relevant and how to best assess it with imaging? CAD, CMR, DSE, LV
83  2018 Outcome of catheter ablation for ventricular tachycardia in patients with ischemic cardiomyopathy: A systematic review and meta-analysis of randomized clinical trials. ACM, CA, CVD, OR, RR, VT
84  2018 Outcomes in Patients With Hypertrophic Cardiomyopathy Awaiting Heart Transplantation. HCM, HT
85  2018 Overexpression of collagen type III in injured myocardium prevents cardiac systolic dysfunction by changing the balance of collagen distribution. LV, N-OPN, SV
86  2018 Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial: Percutaneous Coronary Intervention for IschemicCardiomyopathy. HF, LVEF, OMT, PCI
87  2018 Prediction of the ischemic origin of functional mitral regurgitation in patients with systolic heart failure through posterior mitral leaflet angle. CD, CI, DCM, FMR, MV, OR, Sm, TA, TDI
88  2018 Qualitative and Quantitative Analysis of Cardiac Progenitor Cells in Cases of Myocarditis and Cardiomyopathy. CPC, DCM
89  2018 Quantitative deformation analysis differentiates ischaemic and non-ischaemic cardiomyopathy: sub-group analysis of the VINDICATE trial. CMR, HF, LV, LVEF, NICM
90  2018 Respiratory Sinus Arrhythmia Quantified with Linear and Non-Linear Techniques to Classify Dilated and Ischemic Cardiomyopathy. CHF, DCM, DM, RSA
91  2018 Role of Myocardial Perfusion Study in Differentiating Ischemic versus Nonischemic Cardiomyopathy Using Quantitative Parameters. CAG, EDV, EF, ESV, MPI, NICM, NPV, PPV, SDS, SRS
92  2018 Scar burden, not intraventricular conduction delay pattern, is associated with outcomes in ischemic cardiomyopathy patients receiving cardiac resynchronization therapy. CRT, IVCD, LBBB, LVEF
93  2018 Sympathetic denervation in patients with ischemic cardiomyopathy and risk on ventricular tachy-arrhythmias. A pilot study. ICD, LVEF
94  2018 The Relationship between Serum Zinc Level and Heart Failure: A Meta-Analysis. HF, IDCM
95  2018 Therapeutic efficacy and safety of Shexiang Baoxin Pill combined with trimetazidine in elderly patients with heart failure secondary to ischaemic cardiomyopathy: A systematic review and meta-analysis. 6MWD, HF, LVEDD, LVEF, LVESD, RCTs, SBP
96  2018 Transcriptome Profiling Reveals PHLDA1 as a Novel Molecular Marker for Ischemic Cardiomyopathy. ---
97  2018 Transplantation of Endothelial Progenitor Cells Overexpressing miR-126-3p Improves Heart Function in Ischemic Cardiomyopathy. EPCs, MO-EPCs, NM-EPCs
98  2017 A real world wearable cardioverter defibrillator experience - Very high appropriate shock rate in ischemic cardiomyopathy patients at a European single-center. SCD, VA, WCD
99  2017 Aberrant Epicardial Adipose Tissue Extracellular Matrix Remodeling in Patients with Severe Ischemic Cardiomyopathy: Insight from Comparative Quantitative Proteomics. CAD, EAT, ECM, GO, PSR
100  2017 Adding Defibrillation Therapy to CardiacResynchronization on the Basisofthe MyocardialSubstrate. CI, CRT, DCM